查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1617855

吸入麻醉劑市場：按類型、作用持續時間、應用和最終用途 - 2025-2030 年全球預測

Inhalation Anesthetics Market by Type (Desflurane, Halothane, Isoflurane), Duration of Action (Long-acting, Short-acting), Application, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年吸入麻醉劑市場價值為17億美元，預計到2024年將達到18.8億美元，複合年成長率為11.01%，預計到2030年將達到35.4億美元。

吸入麻醉劑市場包括各種主要用於外科手術過程中誘導和維持全身麻醉的氣體製劑。這些藥物包括SEVOFLURANE、DESFLURANE、Isoflurane等，對於確保患者固定、失憶和鎮痛至關重要。由於人口老化以及心血管疾病和癌症等慢性疾病盛行率的增加，全世界進行的外科手術數量不斷增加，證明了對吸入麻醉劑的需求。這些麻醉劑擴大用於牙科手術、獸醫手術、門診病人以及醫院和門診手術中心，擴大了最終用途的範圍。

主要市場統計
基準年[2023] 17億美元
預計年份 [2024] 18.8億美元
預測年份 [2030] 35.4億美元
複合年成長率（%） 11.01%

市場成長受到技術創新的顯著影響，例如醫療保健基礎設施的進步、外科手術的增加以及麻醉輸送系統的發展。此外，對微創手術的需求不斷成長，以及吸入麻醉劑與靜脈注射麻醉劑相比的成本效益也帶來了巨大的成長機會。然而，嚴格的監管核准、潛在的副作用以及溫室氣體排放的環境問題等挑戰正在阻礙市場擴張。開發中地區的價格敏感度也增加了限制。

為了利用市場機會，鼓勵公司專注研究和開發副作用更少、環境影響更小的新型麻醉劑。強調對醫療保健提供者進行關於這些藥物的安全使用和處理的教育可以提高市場滲透率。此外，與醫療組織合作並進入外科手術需求量大的區域市場可以提供利潤豐厚的成長途徑。創新技術包括最佳化給藥效率和環境足跡的藥物傳輸系統。總體而言，儘管存在監管和環境挑戰，但市場競爭激烈，醫療實踐和技術的進步推動了市場成長。

市場動態：揭示快速發展的吸入麻醉劑市場的關鍵市場洞察

供需的動態交互作用正在改變吸入麻醉劑市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球手術和慢性病數量的增加以及對微創治療的需求
    • 政府對外科手術的核准和報銷政策優惠
  • 市場限制因素
    • 與吸入麻醉劑產品召回相關的潛在風險
  • 市場機會
    • 整合有效的奈米藥物輸送系統用於吸入麻醉劑
    • 投資合成和麻醉劑鴉片類麻醉劑的研發
  • 市場挑戰
    • 與吸入麻醉劑相關的副作用

波特五力：駕馭吸入麻醉劑市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解吸入麻醉劑市場的外部影響

外部宏觀環境因素在塑造吸入麻醉劑市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解吸入麻醉劑市場的競爭狀況

對吸入麻醉劑市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣吸入麻醉劑市場供應商的績效評估

FPNV 定位矩陣是評估吸入麻醉劑市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃吸入麻醉劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對吸入麻醉劑市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的手術和慢性病數量不斷增加，增加了對微創治療方案的需求。
      • 政府對外科手術的核准和報銷政策優惠
    • 抑制因素
      • 與吸入麻醉劑產品召回相關的潛在風險
    • 機會
      • 整合有效的奈米藥物輸送系統用於吸入麻醉劑
      • 投資合成和非鴉片類麻醉劑的研發
    • 任務
      • 與吸入麻醉劑相關的副作用
  • 市場區隔分析
    • 類型：DESFLURANE因其具有快速恢復、可預測性和頭腦清晰的優點而被用作麻醉劑。
    • 應用：在複雜的手術過程中擴大使用吸入麻醉劑來控制疼痛
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章吸入麻醉劑市場：依類型

  • DESFLURANE
  • 氟烷
  • Isoflurane
  • 氧化亞氮
  • SEVOFLURANE

第7章吸入麻醉劑市場按作用持續時間

  • 長效
  • 短效

第8章吸入麻醉劑市場：依應用分類

  • 診斷程序
  • 緊急護理
  • 外科手術
    • 心血管外科
    • 一般外科
    • 婦科手術
    • 神經外科
    • 整形外科

第9章吸入麻醉劑市場：依最終用途

  • 門診手術中心
  • 醫院

第10章美洲吸入麻醉劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太吸入麻醉劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲吸入麻醉劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • AANA 發布麻醉氣體廢棄物安全處置新指南
    • Benenden 醫院採用 Sage Tech Medical 的環保麻醉氣體回收技術
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Aesica Queenborough Limited
  • Akorn, Inc.
  • Aspen Pharmacare Holdings Limited
  • Baxter International Inc.
  • BOC Healthcare
  • Draegerwerk AG & Co. KGaA
  • Eagle Pharmaceuticals
  • Fresenius Kabi AG
  • GE HealthCare Technologies, Inc.
  • Halocarbon Life Sciences
  • Hikma Pharmaceuticals PLC
  • Intersurgical Ltd
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Linde PLC
  • Lunan Pharmaceutical Group Co. Ltd.
  • Maruishi Pharmaceutical Co., Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Piramal Enterprises Limited
  • Teligent, Inc.
  • Troikaa Pharmaceuticals Ltd.
  • Vigon International Inc.
  • Yichang Humanwell Pharmaceutical Co., Ltd.
  • Zoetis Inc.
Product Code: MRR-742BD517FC4B

The Inhalation Anesthetics Market was valued at USD 1.70 billion in 2023, expected to reach USD 1.88 billion in 2024, and is projected to grow at a CAGR of 11.01%, to USD 3.54 billion by 2030.

The inhalation anesthetics market encompasses a range of gaseous agents used primarily for the induction and maintenance of general anesthesia during surgical procedures. These agents include sevoflurane, desflurane, and isoflurane, among others, and are integral in ensuring patient immobilization, amnesia, and analgesia. The necessity for inhalation anesthetics is underscored by the growing number of surgical procedures globally, driven by an aging population and the increasing prevalence of chronic diseases such as cardiovascular disorders and cancer. Beyond hospitals and ambulatory surgical centers, these anesthetics are increasingly being utilized in dental procedures, veterinary surgeries, and outpatient settings, thus expanding their end-use scope.

KEY MARKET STATISTICS
Base Year [2023] USD 1.70 billion
Estimated Year [2024] USD 1.88 billion
Forecast Year [2030] USD 3.54 billion
CAGR (%) 11.01%

Market growth is significantly influenced by advancements in healthcare infrastructure, a rise in surgical procedures, and technological innovations like the development of anesthesia delivery systems. Additionally, the growing demand for minimally invasive surgeries and the cost-effectiveness of inhalation anesthetics compared to intravenous alternatives present substantial growth opportunities. However, challenges such as stringent regulatory approvals, potential side effects, and environmental concerns related to greenhouse gas emissions hinder market expansion. Price sensitivity in developing regions also adds to the limitations.

To capitalize on market opportunities, companies are advised to focus on research and development of newer anesthetic agents with reduced side effects and lower environmental impact. Emphasizing education for healthcare providers regarding the safe use and handling of these agents can enhance market penetration. Furthermore, partnerships with medical associations and participation in regional markets with high surgical demand can offer lucrative growth avenues. Innovations could target drug delivery systems that optimize dosing efficiency and environmental footprint. Overall, the market is competitive but poised for growth, driven by evolving medical practices and technology, despite underlying regulatory and environmental challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhalation Anesthetics Market

The Inhalation Anesthetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the number of surgeries and chronic diseases globally and the need for minimally invasive treatment options
    • Favorable government approvals and reimbursement policies for surgical procedures
  • Market Restraints
    • Potential risk associated with the product recall of inhalation anesthetic drugs
  • Market Opportunities
    • Integration of nano-based drug delivery systems for effective inhalation anesthetics
    • Investment in R&D for synthetic and non-opioid anesthetics
  • Market Challenges
    • Side effects associated with inhalation anesthetic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Inhalation Anesthetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhalation Anesthetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhalation Anesthetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhalation Anesthetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhalation Anesthetics Market

A detailed market share analysis in the Inhalation Anesthetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhalation Anesthetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhalation Anesthetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Inhalation Anesthetics Market

A strategic analysis of the Inhalation Anesthetics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Inhalation Anesthetics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aesica Queenborough Limited, Akorn, Inc., Aspen Pharmacare Holdings Limited, Baxter International Inc., BOC Healthcare, Draegerwerk AG & Co. KGaA, Eagle Pharmaceuticals, Fresenius Kabi AG, GE HealthCare Technologies, Inc., Halocarbon Life Sciences, Hikma Pharmaceuticals PLC, Intersurgical Ltd, Jiangsu Hengrui Medicine Co., Ltd., Linde PLC, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co., Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc., Piramal Enterprises Limited, Teligent, Inc., Troikaa Pharmaceuticals Ltd., Vigon International Inc., Yichang Humanwell Pharmaceutical Co., Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Inhalation Anesthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Desflurane, Halothane, Isoflurane, Nitrous Oxide, and Sevoflurane.
  • Based on Duration of Action, market is studied across Long-acting and Short-acting.
  • Based on Application, market is studied across Diagnostic Procedures, Emergency Care, and Surgical Procedures. The Surgical Procedures is further studied across Cardiovascular Surgery, General Surgery, Gynecological Surgery, Neurosurgery, and Orthopedic Surgery.
  • Based on End Use, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the number of surgeries and chronic diseases globally and the need for minimally invasive treatment options
      • 5.1.1.2. Favorable government approvals and reimbursement policies for surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk associated with the product recall of inhalation anesthetic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of nano-based drug delivery systems for effective inhalation anesthetics
      • 5.1.3.2. Investment in R&D for synthetic and non-opioid anesthetics
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with inhalation anesthetic drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Utilization of Desflurane in anesthetics due to its advantage in rapid, predictable, and clear-headed recovery
    • 5.2.2. Application: Increasing usage of inhalation anesthetics for pain management in complex surgery process
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Inhalation Anesthetics Market, by Type

  • 6.1. Introduction
  • 6.2. Desflurane
  • 6.3. Halothane
  • 6.4. Isoflurane
  • 6.5. Nitrous Oxide
  • 6.6. Sevoflurane

7. Inhalation Anesthetics Market, by Duration of Action

  • 7.1. Introduction
  • 7.2. Long-acting
  • 7.3. Short-acting

8. Inhalation Anesthetics Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Procedures
  • 8.3. Emergency Care
  • 8.4. Surgical Procedures
    • 8.4.1. Cardiovascular Surgery
    • 8.4.2. General Surgery
    • 8.4.3. Gynecological Surgery
    • 8.4.4. Neurosurgery
    • 8.4.5. Orthopedic Surgery

9. Inhalation Anesthetics Market, by End Use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals

10. Americas Inhalation Anesthetics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Inhalation Anesthetics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Inhalation Anesthetics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. AANA issues new guidelines for safe disposal of waste anesthetic gases
    • 13.3.2. Benenden Hospital adopts SageTech Medical's eco-friendly anesthetic gas recycling technology
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aesica Queenborough Limited
  • 3. Akorn, Inc.
  • 4. Aspen Pharmacare Holdings Limited
  • 5. Baxter International Inc.
  • 6. BOC Healthcare
  • 7. Draegerwerk AG & Co. KGaA
  • 8. Eagle Pharmaceuticals
  • 9. Fresenius Kabi AG
  • 10. GE HealthCare Technologies, Inc.
  • 11. Halocarbon Life Sciences
  • 12. Hikma Pharmaceuticals PLC
  • 13. Intersurgical Ltd
  • 14. Jiangsu Hengrui Medicine Co., Ltd.
  • 15. Linde PLC
  • 16. Lunan Pharmaceutical Group Co. Ltd.
  • 17. Maruishi Pharmaceutical Co., Ltd.
  • 18. Merck & Co., Inc.
  • 19. Novartis AG
  • 20. Pfizer Inc.
  • 21. Piramal Enterprises Limited
  • 22. Teligent, Inc.
  • 23. Troikaa Pharmaceuticals Ltd.
  • 24. Vigon International Inc.
  • 25. Yichang Humanwell Pharmaceutical Co., Ltd.
  • 26. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. INHALATION ANESTHETICS MARKET RESEARCH PROCESS
  • FIGURE 2. INHALATION ANESTHETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALATION ANESTHETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INHALATION ANESTHETICS MARKET DYNAMICS
  • TABLE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DESFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HALOTHANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY NITROUS OXIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY EMERGENCY CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY DURATION OF ACTION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 238. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023